The FDA De Novo permission for Samsung Electronics’ sleep apnea function in the Samsung Health Monitor app is a ground-breaking development that makes it the first FDA-authorized feature of its type. Through recording their sleep twice for more than four hours over ten days, individuals over 22 who own compatible Samsung Galaxy watches and phones may use this function to identify symptoms of moderate to severe obstructive sleep apnea (OSA) throughout the course of a two-night monitoring period. In addition to raising the risk of cardiovascular illnesses, OSA can cause poor sleep, weariness throughout the day, and an interruption in the flow of oxygen.
Samsung’s three-pronged approach—understanding sleep patterns, forming healthier habits, and providing a sleep-friendly environment—evidences the company’s dedication to improving sleep health. According to the National Sleep Foundation, 10% of women and 25% of men in the United States suffer from sleep apnea (OSA), and the sleep apnea feature attempts to proactively detect possible health problems. This FDA-approved function, which is anticipated to launch on the Galaxy Watch series in the United States in the third quarter, demonstrates Samsung’s commitment to provide its customers cutting-edge solutions for improved sleep health.